Real World Evidence of Secukinumab and Bimekizumab in Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis

Background and objectives: Evidence for secukinumab and bimekizumab in hidradenitis suppurativa (HS) primarily comes from randomized clinical trials with selected patient populations. Conversely, real-world evidence (RWE) studies reflect broader patient demographics and clinical practice. This study...

Descrición completa

Detalles Bibliográficos

Principais autores:	S. Haselgruber, D. Muñoz-Barba, A. Soto-Moreno, C. Cuenca-Barrales, S. Arias-Santiago, A. Molina-Leyva
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2026-01-01
Series:	Actas Dermo-Sifiliográficas
Assuntos:	Hidradenitis suppurativa Secukinumab Bimekizumab Il-17 inhibitors Biologic drugs
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S0001731025007604
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!